Allergic diseases such as bronchial asthma and atopic dermatitis develop by a combination of genetic and environmental factors. Several candidate causative genes of asthma and atopy have been reported as the genetic factors. The clinical features of patients and causes of diseases vary. Therefore, personalized medicine (tailor-made medicine) is necessary for the improvement of quality of life (QOL) and for asthma cure. Pharmacogenetics is very important for personalized medicine. Here, we present the genetics and pharmacogenetics of asthma in children. Finally, we show the guideline for personalized medicine for asthma, particularly in childhood, including the pharmacogenetics of anti-asthmatic drugs, preliminarily produced by the authors.
Anti-Asthmatic Agents ; Asthma ; Child ; Dermatitis, Atopic ; Humans ; Precision Medicine ; Pharmacogenetics ; Quality of Life

It is important to understand the impact of the COVID-19 pandemic on inpatient care and the needs of inpatients and their families. We conducted an anonymous self-administered questionnaire survey of inpatients who had been referred to our palliative care team, their families (hereafter referred to as patients' families), and their primary nurses (hereafter referred to as PNs). The EZR statistical software was used for statistical analysis, and p<0.05 was considered to indicate a significant difference. 31 patients [9 males, 22 females; median age 65 years (range 30-85 years)], 25 family members, and 26 PNs responded. The question “Do you ever feel depressed due to restricted visitation?” had a significantly stronger impact on patient families than on patients (p<0.05). Compared to patients, patient families tended to prefer face-to-face visits (p<0.05). The impact of visitation restrictions was greater on patients’ families than on the inpatients, suggesting that it is important to provide care and support to patients’ families especially during periods when there are visitation restrictions.

The patient was a 68-year-old woman who was diagnosed with stage IIIA cervical cancer and pyometra. Concurrent chemoradiotherapy was planned. She was admitted to our hospital 3 weeks after the initial examination due to vaginal bleeding and worsening of lower abdominal pain. On hospital day 5, she developed a fever, and free gas in the peritoneal cavity and ascites were confirmed by contrast-enhanced computed tomography. Emergency surgery was performed for suspected generalized peritonitis attributed to perforation in the digestive tract or uterus. A large amount of purulent ascites and 2 perforations in the anterior wall of the uterus, but none in the digestive tract, were observed. Peritoneal lavage and drainage were performed, and a colostomy was created. The patient was managed in the intensive care unit until postoperative day 13 due to septic shock and acute renal failure. After the peritonitis resolved, radiation therapy alone was provided, and then chemotherapy was started to treat residual lesions. Pyometra recurred, and transvaginal drainage was performed to prevent perforation of the uterus. However, a few days later, a colouterine fistula and an enterocutaneous fistula developed simultaneously, and her general condition worsened. In advanced cervical cancer complicated by pyometra, various complications can develop that are difficult to manage (e.g., uterine perforation and fistula formation due to radiation enteritis and dermatitis). 　This case demonstrates the importance of uterine drainage at appropriate timing, which can contribute to improved prognosis.